Study of the impact of a post-acute coronary syndrome pharmaceutical interview in hospital

Objectives. - Post-acute coronary syndrome pharmaceutical interviews were set up in our esta-blishment. The objective of this study was to assess their impact on patient knowledge and their benefit at one year on medication compliance, cardiovascular risk factors (smoking, overweight, dyslipidemia) and the recurrence rate. Methods. - Two groups were formed, an experimental group of patients who had benefited from pharmaceutical interviews and a control group of patients who had not benefited from them. The knowledge of the patients was measured using a quizz carried out before the interview and one month after for the experimental group, then one year after hospitalization for the two groups. A one-year follow-up of medication compliance assessed, control of cardiovascular risk factors and the rate of recurrence of acute coronary syndrome was carried out in both groups.Results. - A significant increase in knowledge (P < 0.001) after the pharmaceutical interview and its maintenance over time were observed in the experimental group. One year after hospi-talization, in the experimental group, the average score on the knowledge quizz (9.2/10) was significantly higher (P < 0.005) than that of the control group (6.6/10); medication compliance was significantly better (P < 0.05) and greater smoking cessation was observed.Conclusions. - These encouraging results should be highlighted in order to perpetuate and develop such approaches around patient care.& COPY; 2022 Academie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.